Belite Bio, Inc

Belite Bio, Incverified

BLTE

Price:

$138.16

Market Cap:

$5.54B

Belite Bio, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and advancement of novel therapies. The firm's primary therapeutic areas include atrophic age-related macular degeneration and autosomal recessive Stargardt disease. Its flagship drug candidate, LBS-008, is an investigational oral medication administered once daily. Currently undergoing Phase 3 clinical trials, LBS-008 is engineered to modulate vitamin A delivery to the eye, thus preventing the accumulation of detrimental vitamin A metabolites in ocular tissues. Furthermore, Belite Bio is advancing LBS-009, an oral anti-retinol binding protein 4 therapy, through preclinical development. This therapy targe...[Read more]

Industry

Biotechnology

IPO Date

2022-04-29

Stock Exchange

NASDAQ

Ticker

BLTE

The Enterprise Value as of June 2026 (TTM) for Belite Bio, Inc (BLTE) is 5.19B

According to Belite Bio, Inc’s latest financial reports and current stock price. The company's current Enterprise Value is 5.19B. This represents a change of 125.60% compared to the average of 2.30B of the last 4 quarters.

Belite Bio, Inc (BLTE) Historical Enterprise Value (quarterly & annually)

How has BLTE Enterprise Value performed in the past?

The mean historical Enterprise Value of Belite Bio, Inc over the last ten years is 1.50B. The current 5.19B Enterprise Value has changed 34.58% with respect to the historical average. Over the past ten years (40 quarters), BLTE's Enterprise Value was at its highest in in the December 2025 quarter at 5.01B. The Enterprise Value was at its lowest in in the March 2026 quarter at 0.

Quarterly (TTM)
Annual

Average

1.50B

Median

845.17M

Minimum

103.68M

Maximum

5.01B

Belite Bio, Inc (BLTE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Belite Bio, Inc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 164.38%

Maximum Annual Enterprise Value = 5.01B

Minimum Annual Increase = 0%

Minimum Annual Enterprise Value = 103.68M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20255.01B164.38%
20241.90B67.87%
20231.13B101.32%
2022560.97M108.05%
2021269.63M160.06%

Belite Bio, Inc (BLTE) Average Enterprise Value

How has BLTE Enterprise Value performed in the past?

The current Enterprise Value of Belite Bio, Inc (BLTE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

2.68B

5-year avg

1.77B

10-year avg

1.50B

Belite Bio, Inc (BLTE) Enterprise Value vs. Peers

How is BLTE’s Enterprise Value compared to its peers?

Belite Bio, Inc’s Enterprise Value is greater than Mirum Pharmaceuticals, Inc. (4.99B), less than Ligand Pharmaceuticals Incorporated (5.46B), greater than ADMA Biologics, Inc. (1.97B), greater than Praxis Precision Medicines, Inc. (5.10B), greater than ACADIA Pharmaceuticals Inc. (3.38B), greater than Soleno Therapeutics, Inc. (2.63B), greater than Dyne Therapeutics, Inc. (2.27B), greater than Arcutis Biotherapeutics, Inc. (3.03B), greater than Viking Therapeutics, Inc. (3.22B), greater than Crinetics Pharmaceuticals, Inc. (3.57B),

Build a custom stock screener for Belite Bio, Inc (BLTE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Belite Bio, Inc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Belite Bio, Inc (BLTE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Belite Bio, Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Belite Bio, Inc's Enterprise Value?

What is the highest Enterprise Value for Belite Bio, Inc (BLTE)?

What is the 3-year average Enterprise Value for Belite Bio, Inc (BLTE)?

What is the 5-year average Enterprise Value for Belite Bio, Inc (BLTE)?

How does the current Enterprise Value for Belite Bio, Inc (BLTE) compare to its historical average?